
Strategic guidance and institutional-grade solutions customized for your enterprise objectives.
Talk to a Financial Expert
India's eye-care sector is becoming increasingly attractive for entrepreneurs, strategic buyers and healthcare investors. The market remains fragmented, while organised eye-care chains continue to expand. CRISIL data cited in a 2025 SEBI filing indicated that organised eye-care chains represented about 13–15% of India's eye-care market in FY2024, leaving substantial room for consolidation. The same source noted growing M&A and investment activity.
That opportunity also creates a valuation challenge. An eye center is not simply a clinic with equipment and a revenue figure. Its value can depend on surgeon reputation, procedure mix, referral networks, patient volumes, diagnostic assets, location, lease terms, working capital and the degree of dependence on the promoter.
Aviaan approaches Business Valuation Services as a decision-making exercise. For an Indian eye center, valuation is combined with financial due diligence, earnings normalisation, cash-flow analysis and transaction-specific risk assessment.

Aviaan starts by separating the seller's asking price from the underlying economic value of the practice. A buyer needs to understand what generates today's earnings and whether those earnings can continue after ownership changes.
The strongest valuation drivers are sustainable earnings, procedure economics, patient volumes, doctor dependence, growth potential, assets, location and transaction risk.
A useful eye center financial analysis typically examines:
For example, two clinics with identical annual revenue may deserve very different valuations. One may have diversified consultants, modern equipment and predictable patient volumes. The other may depend almost entirely on a single founder-doctor.
That distinction becomes critical during ophthalmology M&A.
Aviaan's financial due diligence process tests whether reported performance reflects sustainable commercial performance. FDD is particularly important when a seller presents strong EBITDA but the buyer has limited visibility into underlying transactions.
Aviaan's published FDD approach focuses on earnings quality, revenue sustainability, cash flows, working capital, hidden liabilities and assumptions supporting valuation.
A buyer should validate revenue, normalise earnings, investigate liabilities and reconcile financial performance with operational KPIs.
For an ophthalmology practice acquisition, the review can cover:
The review should also distinguish between revenue that is genuinely recurring and revenue generated by temporary campaigns, exceptional referrals or a particular surgeon.
For buyers, the output is more useful when it connects financial findings to purchase-price implications. A weak receivables cycle, for instance, may require a working-capital adjustment rather than simply being noted as an accounting issue.
Aviaan uses a multi-method valuation framework rather than forcing every eye center into a single formula. Its published valuation methodology includes income-based, market-based and asset-based approaches.
There is no universal method; DCF, earnings, market multiples and asset-based analysis should be reconciled according to the center's maturity, profitability and transaction purpose.
A practical framework is:
| Valuation approach | Useful when | Eye-care considerations |
|---|---|---|
| DCF | Business has predictable growth | Tests future cash generation and reinvestment |
| Earnings/EBITDA | Established profitable center | Requires careful normalisation |
| Market multiples | Relevant transaction comparables exist | Adjust for size, geography and service mix |
| Asset-based | Asset-heavy or distressed business | Useful for equipment and property assessment |
| Scenario analysis | High uncertainty exists | Tests downside, base and growth cases |
For an established eye hospital, DCF can capture future cash flows from capacity expansion, new procedures or additional locations. For a founder-led clinic, maintainable earnings may require adjustments for the owner's clinical role.
The final conclusion should normally be expressed as a reasoned valuation range rather than a falsely precise number.
Where a valuation is legally required under the Companies Act, 2013, Section 247 provides for valuation by an appropriately registered valuer and requires an impartial, true and fair valuation with due diligence.
Healthcare acquisitions require more than financial analysis. Regulatory status, clinical standards, licences, data practices and equipment compliance can influence both risk and post-acquisition investment.
Aviaan incorporates these issues into the commercial interpretation of its valuation rather than treating compliance as a separate checklist.
The buyer should verify applicable clinical-establishment requirements, registrations, professional credentials, licences, contracts, data practices and state-specific healthcare obligations.
The Clinical Establishments (Registration and Regulation) Act, 2010 establishes a framework for registration and minimum standards for covered clinical establishments. The Ministry of Health and Family Welfare also publishes specific ophthalmology standards and guidelines. Applicability varies by state and establishment type, so transaction diligence should be jurisdiction-specific.
Digital health is another growing consideration. India's Ayushman Bharat Digital Mission is developing interoperable health infrastructure, while the Health Facility Registry covers public and private healthcare facilities.
For an acquisition, the buyer should therefore examine:
The Digital Personal Data Protection Act, 2023 also creates a broader framework for lawful processing of digital personal data. Healthcare businesses should assess its implications alongside applicable rules and contractual requirements.
Aviaan combines valuation, financial analysis and transaction-focused due diligence to help eye-center owners and buyers move from an asking price to an evidence-based investment decision.
A typical engagement combines financial review, operating analysis, valuation modelling and scenario testing to produce a defensible view of enterprise and equity value.
Depending on the transaction, Aviaan can support:
The approach can also connect with Financial Modeling and Forecasting Services in India when an investor needs a detailed model covering capacity, procedures, pricing, staffing, capital expenditure and expansion scenarios.
For owners preparing for sale, valuation can identify weaknesses before buyers discover them. For acquirers, FDD can highlight issues that justify a lower price, stronger warranties or transaction conditions.
The value of an adviser is not simply the valuation number. It is the ability to explain what drives that number and how the risks affect the transaction.
The adviser should provide transparent assumptions, an appropriate methodology, documented calculations and clear commercial interpretation.
Aviaan's published valuation practice emphasises independent analysis, multiple valuation methods, detailed financial modelling, sensitivity analysis and transparent assumptions.
Relevant capabilities for an Indian eye-center engagement include:
Where a statutory valuation requires a registered valuer, the appropriate qualified professional should be appointed in accordance with applicable Indian law.
Good source data improves both speed and reliability. Owners or sellers should prepare:
A buyer should ideally request the same information through a structured due-diligence data room.
There is no single standard fee because valuation complexity varies by size, locations, transaction purpose and data availability. A standalone clinic requires a different scope from a multi-location eye hospital or acquisition target. The best approach is to define the valuation objective and diligence scope before pricing the engagement.
No. EBITDA is an important indicator, but it should not be used in isolation. Doctor dependence, procedure mix, capital expenditure, working capital, location, growth prospects and liabilities can materially change value.
Ideally, financial due diligence and valuation should inform each other. Preliminary valuation can establish a transaction range, while FDD tests whether the earnings and assumptions supporting that range are reliable.
Yes, if its future cash flows can be forecast with reasonable confidence. For a small founder-led practice, however, maintainable earnings and scenario analysis may be equally important because owner dependence can materially affect future cash generation.
Ideally, before entering serious sale, investment or partnership negotiations. Early valuation gives the owner time to correct financial reporting gaps, strengthen operations, reduce avoidable risks and build a more defensible negotiation position.
A strong eye-care business can offer attractive opportunities for expansion and consolidation, but transaction value should never be based solely on revenue, equipment or a seller's preferred multiple.
Business Valuation & FDD for Eye Centers in India provides a more complete decision framework. It connects sustainable earnings, clinical operations, assets, doctor dependency, regulatory exposure, cash flow and growth potential.
For owners considering an exit, investors assessing an ophthalmology practice acquisition, or strategic buyers evaluating an eye hospital, Aviaan can help turn financial information into a clearer valuation and transaction strategy.
Explore Aviaan's Business Valuation Services to discuss an India-focused eye-center valuation, financial due diligence or acquisition analysis.
Talk to an Expert
Schedule a complimentary 30-minute discovery call to discuss your requirements.
Recent Insights



Need Immediate Help?
Let's Build Your Business Success Together
Our senior partners are available to evaluate your current financial structure and identify opportunities for optimization and risk reduction.
Our advisory assignments span a wide range of industries, including:
Each sector requires different demand drivers, economics, competitive factors and valuation considerations. Our analysis is structured accordingly.
Industries We Serve
Real Estate
Healthcare
Manufacturing
Technology
Retail & E comm
Logistics
Services Offered by Aviaan
Feasibility Study
Business Plan
A comprehensive analysis to evaluate the commercial, technical, and financial viability of a proposed business or project before investment.
Business Valuation
An objective assessment of a company, asset, or investment to determine its fair market value for transactions, reporting, or strategic decisions.
Due Diligence
A detailed financial review to assess risks, validate performance, and ensure informed decision-making in transactions.
Accounting
End-to-end financial recording, reporting, and compliance services to maintain accurate books and support business decision-making.
Market Research
Launching a new venture, expanding into a new geography, raising capital, or entering a new segment, robust market research is critical.
Need Immediate Help?
Independent verification of financial statements to ensure transparency and trust.
LEARN MORE →A comprehensive analysis to evaluate the commercial, technical, and financial viability of a proposed business or project before investment.
LEARN MORE →An objective assessment of a company, asset, or investment to determine its fair market value for transactions, reporting, or strategic decisions.
LEARN MORE →A detailed financial review to assess risks, validate performance, and ensure informed decision-making in transactions.
LEARN MORE →End-to-end financial recording, reporting, and compliance services to maintain accurate books and support business decision-making.
LEARN MORE →Launching a new venture, expanding into a new geography, raising capital, or entering a new segment, robust market research is critical.
LEARN MORE →Ready to Speak with an Expert?
Partner with Aviaan Advisory today to unlock your business’s full potential. Our team of experts is here
to provide tailored solutions and guide you every step of the way.